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A fast 50 mm-accuracy alignment procedure has been developed for the
radiosurgery of brain lesions in rats, using microbeam radiation therapy. In vivo
imaging was performed using the pink beam (35–60 keV) produced by the ID17
wiggler at the ESRF opened at 120 mm and ﬁltered. A graphical user interface
has been developed in order to deﬁne the irradiation ﬁeld size and to position
the target with respect to the skull structures observed in X-ray images. The
method proposed here allows tremendous time saving by skipping the swap
from white beam to monochromatic beam and vice versa. To validate the
concept, the somatosensory cortex or thalamus of GAERS rats were irradiated
under several ports using this alignment procedure. The magnetic resonance
images acquired after contrast agent injection showed that the irradiations were
selectively performed in these two expected brain regions. Image-guided
microbeam irradiations have therefore been realised for the ﬁrst time ever, and,
thanks to this new development, the ID17 biomedical beamline provides a major
tool allowing brain radiosurgery trials on animal patients.
Keywords: synchrotron microbeam radiation therapy; pink-beam imaging; alignment
procedure; preclinical brain radiosurgery.
1. Introduction
For the last two decades, several preclinical studies have
highlighted the potential role of synchrotron light for medical
applications and particularly for brain radiosurgery (Bouchet
et al., 2010; Laissue et al., 1998; Serduc, Bouchet et al., 2009;
Serduc, Christen et al., 2008). Microbeam radiation therapy
(MRT) (Slatkin et al., 1992) was ﬁrst dedicated to preclinical
brain tumor treatments. It is based on the spatial fractionation
of the incident X-ray beam into an array of quasi-parallel
microbeams (a few tens of micrometres wide). This unique
irradiation geometry allows high dose deposition (hundreds
of Gray) in rodent brains without inducing severe tissular
damages when delivered unidirectionally (Laissue et al., 1998;
Slatkin et al., 1995; Serduc, van de Looij et al., 2008; Serduc et
al., 2006). However, therapeutic applications require several
irradiation ports that might impair normal brain structures
contiguous to the radiation target. Previous works revealed
that lesion targeting used in preclinical experiments must be
now adapted to clinical standards (Bouchet et al., 2010;
Laissue et al., 1998; Serduc, Brauer-Krisch et al., 2009) and that
image-guided irradiations would considerably increase the
therapeutic index of MRT in cancer treatment. Furthermore,
high-precision alignment of the irradiation ﬁelds opens new
perspectives in preclinical neurosciences. For instances, high-
dose MRT-induced focal necrosis of a clearly identiﬁed
epileptogenic focus or subthalamic nucleus might be very
informative in epilepsy or Parkinson pathologies.
The biomedical beamline (ID17) of the European
Synchrotron Radiation Facility (ESRF, Grenoble, France) is
devoted to the applications of synchrotron radiation to the
medical domains such as X-ray imaging and radiotherapy. The
know-how acquired in imaging has permitted a new image-
guided method for animal positioning and alignment for brain
MRT to be developed. The white beam produced by the ID17
wiggler has been used for radiographic imaging, and a
specially developed computer-interfaced system has allowed
precise irradiation ﬁeld deﬁnition and radiation target posi-
tioning in the rat head within  50 mm accuracy, based on skull
structures.
2. MRT principle review
Microbeam irradiations of rat brain were performed at the
ID17 dedicated hutch located at the front part of the beamline.
For this application, the wiggler source (21-pole wiggler, 15 cm
period, 1.6 T maximum ﬁeld), located at41 m from the sample,
produces a white spectrum of photons which extends afterﬁltration from 50 to 350 keV with a maximum intensity at
83 keV (Fig. 1) (Bra ¨uer-Krisch et al., 2003). Only the central
cone of the synchrotron beam (0.05 mm high, 4 cm wide)
was selected by calibrated slits. The quasi-laminar beam was
then spatially fractionated into an array of quasi-parallel
microbeams by using an adjustable multi-slit collimator
(Bra ¨uer-Krisch et al., 2005, 2009; Archer, 1998) positioned
about 80 cm upstream from the head of the animals.
Microbeams used in MRT can vary between 25 and 100 mmi n
width and the distance between two microbeams is typically
100–400 mm. The dose rate in the air reaches  16000 Gy s
 1.
For preclinical studies, the animals are ﬁxed on a high-preci-
sion goniometer and are vertically scanned through the
microbeam array in order to restore the second dimension of
the irradiation ﬁeld from the original horizontal laminar beam.
The goniometer vertical motor is remotely controlled and the
translation speed, which determines the X-ray dose delivered
to the tissues, is kept constant to within a few percent by a
feedback system. The vertical ﬁeld of irradiation is determined
by hardware synchronization between the opening of two fast
shutters and the vertical motion encoders. Adjustment of the
dose is made by calibrating the goniometer speed with respect
to the intensity of the electron current circulating in the
storage ring.A one-port irradiation lasts  20 ms with atypical
speed of 20 mm s
 1.
3. Imaging, alignment and irradiation protocols
3.1. Imaging method
A two-dimensional X-ray imaging detector is installed
about 2 m downstream of the animal goniometer to accurately
align the samples with respect to the microbeams. The
detector is a tapered optic fast-readout low-noise (FReLoN)
CCD camera developed at the ESRF for a broad range of
applications; its speciﬁcations were initially tailored for
computed tomography in diffraction enhanced imaging
mammography (Bravin et al., 2003). The CCD is a 2048   2048
pixel chip from Atmel, USA. The size of the chip is 30 mm  
30 mm and the pixel size is around 14 mm   14 mm. This CCD
chip is coupled with a tapered optic which is a bunch of optical
ﬁbres permitting enlargement of the ﬁeld of view of the
detector. Finally the main spatial characteristics of this
detector, which is a standard at ID17, are a ﬁeld of view of
95 mm   95 mm and a pixel size of 47 mm   47 mm, which are
fully reasonable for the alignment precision required for
small-animal in vivo irradiation. The impinging X-rays are
converted to visible light thanks to a thin gadolinium-based
ﬂuorescent screen ﬂattened on the taper entrance. A complete
study of this detector can be found by Coan et al. (2006).
The main positioning uncertainty of the sample with respect
to the irradiation ﬁeld comes from the limited spatial resolu-
tion of the detector. Indeed, the motorized positioning devices
have been designed to meet the requirements of the interlaced
geometry irradiations (Serduc et al., 2010): the lateral parasite
displacements during the vertical motion are not more than
5 mm. This precision has been conﬁrmed by irradiating X-ray-
sensitive ﬁlm in the interlaced geometry mode. Other posi-
tioning uncertainty is due to motion of the animal. However,
the animal is anesthetized and the contention system is sufﬁ-
ciently rigid to ensure a good immobility.
The detector obviously cannot endure the high levels of
radiation used for MRT and the characteristics of the beam
must therefore be softened. Until now, this was done by
inserting a double Laue monochromator into the beam path
before the target. Another option to reduce the photon ﬂux is
to open the wiggler gap until the detector signal falls within its
dynamic range for a minimum exposure time. This latter
solution was selected and completed by ﬁltering the incident
beam with thin metal foils. A ﬁrst set of aluminium ﬁlters (e.g.
3 mm thickness), protected by a 1.5 mm-thick carbon ﬁlter,
permits the low energy part of the spectrum to be removed. It
is followed by a set of copper ﬁlters whose thickness may be
adjusted from 0.5 to 6 mm. Tuning the balance of the wiggler
gap aperture (120 mm, corresponding to a 0.13 T ﬁeld) and the
copper thickness (1.3 mm), we obtained a so-called ‘pink
beam’, as shown in Fig. 1, where both spectra (calculated using
the X-ray code developed at ESRF
1) for therapy (gap aper-
ture 24.8 mm) and imaging (gap aperture 120 mm) are
displayed. For this latter value one can see that the remaining
beam extends from 35 to 60 keV which is appropriate for
small-animal imaging at conventional radiographic doses (Le
Duc et al., 2000).
As described in the previous section, the beam issued from
the wiggler is horizontal and laminar. When all the slits are
removed from the beam, its dimensions are typically 40 mm
horizontal and 1 mm vertical. In order to obtain a two-
dimensional image the animal is vertically scanned through
the beam. An acquisition is triggered on the camera at each
vertical position of the goniometer, with a 1 mm step. The
acquired frames are then piled-up in order to restore the
vertical dimension. A typical in vivo image of a rat brain is
shown in Fig. 2. The vertical ﬁeld of view is almost 20 mm (20
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Figure 1
Photon beam spectra for the two considered apertures of the ID17
wiggler. Wiggler gaps of 24.8 and 120 mm (1.6 Tand 0.13 T magnetic ﬁeld
of the 21 pole, 15 cm-period wiggler) are used for therapy and imaging,
respectively. The increase in the wiggler gap aperture from 24.8 to
120 mm reduces the photon ﬂux by a factor of 6   10
3.
1 Available at http://www.esrf.fr/Accelerators/Groups/InsertionDevices/Soft
ware/Xray.frames). The typical exposure time per frame is 0.1 s. Including
the CCD readout time and the vertical motion operation time,
the total acquisition time of an image is less than 20 s. As
shown in Fig. 2, one can clearly distinguish in this image the
eyes, the ears, the skull or the olfactory bulb, and also the
bregma which is the reference point in rat brain atlas (Paxinos
& Watson, 2004) and which is used for all brain radiosurgery
procedures.
3.2. Multi-slit calibration and central pixel definition
To precisely deﬁne the irradiation ﬁeld, a multi-slit colli-
mator (Bra ¨uer-Krisch et al., 2009) is
brought into the beam. By adjusting the
horizontal offset and the horizontal
aperture of the primary slits located at
the beginning of the beamline, one is
able to deﬁne the central microbeam as
shown in Fig. 3(a). Knowing the inci-
dent beam geometry makes it conse-
quently easy to compute the horizontal
aperture of the primary slits in order to
cover the desired horizontal irradiation
ﬁeld (HIF) containing an integer
number of microbeams as shown in Figs.
3(b) (three microbeams for 850 mm
HIF), 3(c) (ﬁve microbeams for
1.65 mm HIF) and 3(d) (13 microbeams
for 4.85 mm HIF). The maximum ﬁeld
corresponds to the maximum beam size,
e.g. 100 microbeams for a 40 mm HIF.
The central pixel is then deﬁned by the
centroid of the central microbeam
proﬁle. The lateral adjustment (y
direction) of the brain zone to be irra-
diated will be deﬁned around this point in the graphical user
interface described in the following section.
3.3. Alignment method
A dedicated graphical user interface has been developed to
control both the imaging and the radiation therapy. A screen
shot of the imaging part of this application is depicted in Fig. 4.
The beam position height and the pixel number on the camera
corresponding to the centroid of the central microbeam
(previously deﬁned) are manually reported in the X-ray image
(horizontal and vertical white lines, respectively, in Fig. 4). The
operator then deﬁnes the irradiation ﬁeld size and the radia-
tion target can be freely moved on the X-ray image. For any
position of the radiation target the software calculates the z
and y distances from the centre of the radiation target to the
beam position and to the central microbeam pixel, respec-
tively (distances given by lines 3 and 6 in Fig. 4). These
distance corrections will be applied to the z and y motors in
order to align the centre of the radiation target deﬁned in the
rat head with the beam height and the central microbeam of
the array (symbolized by the intersection point of the two
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Figure 2
A typical in vivo beam-eye-view X-ray image obtained for a rat head
using our imaging methods. The principal anatomical characteristics are
clearly visible: eye (E), skin (S), hair (H), ears (Ea), olfactory bulb (OB)
and parietal lobe (PL). Furthermore, the skull surface (Sk), the bregma
(B) and lambda (L), reference points used in the rat head atlas for
stereotactic surgery, are easily located (arrows).
Figure 3
Snapshot of the detector showing the beam across the multi-slit
collimator for different openings of the horizontal primary slits which
delimit the irradiation ﬁeld.
Figure 4
Graphical user interface used for irradiation ﬁeld positioning in the rat head. The horizontal white
line represents the beam and the rotation axis positions (deﬁned by line 4). The vertical white line
corresponds to the central microbeam y position (deﬁned by line 5). The width and height of the
irradiation ﬁeld (grey on the X-ray image) are deﬁned by line 2. For line 1, the user can also indicate
an offset distance (4 mm from the skull surface in this case, white dashed arrow) between the centre
of the irradiation ﬁeld and a given anatomical reference (bregma, black arrow). Two motor motions
in the y and z directions are required to move the target into the beam. These are automatically
calculated when positioning the radiation target and are given by line 3 (y motion) and line 6 (z
motion).perpendicular white lines in the X-ray image in Fig. 4). No
corrections are carried out on the x axis because it corre-
sponds to the beam direction.
3.4. Imaging to therapy mode transition
Dedicated software which drives all the useful motors has
been developed to swap from the imaging to the therapy
mode. The FReLoN camera is protected from high radiation
doses delivered during therapeutical irradiation by moving it
into a lead-shielded box. In addition, the program adds a
50 mm vertical slit for beam height deﬁnition and closes the
primary slits to the central microbeam position (as shown in
Fig. 3a). In the meantime, the wiggler gap is closed to its
irradiation position, namely 24.8 mm at the ESRF-ID17. The
control program then sets the irradiation ﬁeld size in the y
direction by modifying the number of microbeams. The
symmetric opening of the primary slits (procedure described
in x3.2) adds the required number of microbeams on each side
of the central microbeam and deﬁnes the ﬁnal radiation target
size. Moving from imaging to therapy modes lasts for less than
one minute.
4. Biomedical applications
As suggested in the Introduction, the precise alignment
procedure developed in this work opens new perspectives in
preclinical neuroscience. Indeed, until now MRT was limited
to brain tumor treatment but homogeneous irradiation at high
doses delivered to a speciﬁc brain structure will induce
macroscopic necrosis and would give important information
on the role of such brain regions in neurological pathology. It
has been supposed that the somatosensory cortex would
initiate the spontaneous epileptic seizures in the genetic
absence epilepsy rats from Strasbourg (GAERS) while the
thalamus would be involved in their control (David et al., 2008;
Polack et al., 2007). Based on stereotactic coordinates, we
performed three-dimensional bilateral interlaced irradiations
(Serduc et al., 2010) in the somatosensory cortex and thalamus
of GAERS in order to inactivate these two brain regions.
2 The
roles of the somatosensory cortex and thalamus in epileptic
seizures are being studied weekly by electroencephalograms
for several months and will be described elsewhere.
The irradiation ﬁeld alignment was performed by using the
procedure described in this study. The GAERS rat heads (n =
10) were imaged using pink-beam imaging and the radiation
targets were then delimited on the graphical user interface.
The coordinates of the centres of the irradiation ﬁelds for the
cortex were  5 mm laterally from the medio-lateral (ML) line
(left and right hemisphere irradiations),  2.5 mm in the
dorso-ventral (DV) below the skull surface and  0.88 mm in
the anteroposterior (AP, e.g. from the tail to the nose of the
animal) direction from the bregma (noted ‘B’ in Fig. 2). The
irradiation ﬁeld size was 6.15 mm   2m m   2 mm. For
thalamus irradiation, the coordinates were  2.6 mm ML,
 5.3 mm DV and  2.7 mm AP (irradiation ﬁeld size 1.9 mm
  1.5 mm   1.5 mm). All irradiation coordinates were chosen
according to David et al. (2008) who showed that the S1 cortex
and thalamus are activated during seizures in the GAERS rat
model. The irradiations were performed across four entrance
ports by rotating the animal every 45  around its antero-
posterior axis (‘Broch’ in Fig. 4) hence providing four inter-
laced arrays of 50 mm-wide microbeams spaced by 200 mm on-
centre. This operation was then repeated to irradiate the
symmetrical structure target. The in-microbeam entrance dose
was 200 Gy. It has been shown that the irradiation geometry
used in this example induces a blood brain barrier disruption
and contrast agent diffusion in the rat brain conﬁned to the
radiation target (Serduc et al., 2010).
Fig. 5 shows T1-weighted magnetic resonance (MR) images
acquired 15 days after the irradiations in the cortex and the
thalamus of the GAERS rats. MR imaging experiments were
performed at 7 T (Bruker Avance III system) using a quad-
rature volume coil. MR imaging experiments were performed
at the MRI platform of the Grenoble Institut des Neuro-
sciences (Grenoble, France). After anesthesia, a catheter ﬁlled
with heparinized saline was inserted into the dorsal tail vein
of the animal. Radiation-induced changes in brain vessel
permeability were then characterized using a T1-weighted MR
sequence (RARE sequence; TR: 950 ms, effective TE: 7.7 ms,
FOV: 3 cm   3 cm, matrix: 64   64, 0.5 mm-thick) acquired
5 min after an intravenous injection of Gd-DOTA
(200 mmol kg
 1). The contrast agent diffusion (hypersignal)
revealed that the irradiations were performed in the expected
brain regions. This level of precision was reached for nine rats
out of ten. A small angle (few degrees) of one rat head in the
anteroposterior axis during the irradiation induced an error of
less than 1 mm in the irradiation ﬁeld positioning.
5. Discussion
In this study we developed a new method to perform fast
imaging of rat heads allowing a 50 mm accuracy alignment for
MRT preclinical neurological studies. Using the ﬁltered pink
beam produced by the wiggler source at low magnetic ﬁeld,
and thus avoiding the insertion and alignment of the mono-
chromator, limits the number of slits/motor motions required
between imaging and therapy modes. Thanks to this time
saving, the complete cycle comprising imaging, alignment,
transition to therapy mode and actual MRT irradiation took
about 3 min. We have irradiated speciﬁc brain regions of the
GAERS rats (e.g. epileptic foci) to validate this alignment
procedure. As displayed on the MR images, the bilateral
irradiations were performed in the expected brain structures.
Standard synchrotron radiation medical imaging uses highly
monochromatic radiation [(Keyrilainen et al., 2008) ﬂat
Si(333) Bragg crystals, energy bandwidth (bw)  10
 4], quasi-
monochromatic X-ray beams [(Alric et al., 2008) bent Laue
crystals, bw  10
 3] or even larger energy spread radiation
[(Adam et al., 2003; Bayat et al., 2009; Bertrand et al., 2005)
single bent Laue crystal, energy bw  10
 2]. The aim of the
monochromatic imaging is often to obtain quantitative data in
research papers
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2 All operative procedures related to animal care strictly conformed to the
Guidelines of the French Government with licenses 380324 and A3818510002.order to measure the concentration of a contrast agent (e.g.
iodine, xenon or gadolinium) injected in the circulatory system
of the animal. MRT preclinical studies recently moved to brain
pathologies in which quantitative contrast agent imaging is
not required. Non-cancerous brain lesions, i.e. epilepsy or
Parkinson disease, are treated by conventional radiosurgery
and then might be relevant pathologies for MRTapplications
as well (Sims et al., 1999; Kurita et al., 2000; Hadjipanayis et al.,
2001; Romanelli & Anschel, 2006; Tamura et al., 2009). For
instance, radiosurgical neuro-ablation of the subthalamic
nucleus might be a good alternative to the very expensive
deep brain stimulation-based treatment in Parkinson’s
disease. However, preclinical validation of these assumptions
requires a high-precision alignment and targeting procedures
which were not available in MRT studies until now. In such
diseases, no diffusion and accumulation of the imaging
contrast agent are foreseen since normal brain capillaries
exhibit a non-permeable blood brain barrier (Cornford &
Hyman, 1999). Thus, the pink-beam imaging method
described in this work for non-cancerous brain pathologies
presents numerous advantages over commonly used mono-
chromatic imaging. It simpliﬁes considerably the imaging/
therapy transitions. Indeed, the insertion of the mono-
chromator into the beam is a complicated and long-lasting
operation ( 20 min), as several actuators have to be tuned.
Since the monochromator deviates the beam vertically by
15 mm relative to the irradiation white-beam axis, the whole
set-up including slits, attenuators and shutters must be lifted to
this monochromatic beam position. The two monochromator
crystals must be inserted and their orientation carefully tuned
in order to obtain a homogeneous
monochromatic beam. Some time may
also be lost in reaching the necessary
thermal stability of the crystals. The
main difﬁculty is then to obtain an exact
correlation between the monochromatic
beam and the ﬁltered white synchrotron
radiation beam used for the treatment
in such a way that the image corre-
sponds precisely to the irradiation ﬁeld.
This is particularly the case in precli-
nical studies where high numbers of
specimens are imaged and then irra-
diated which requires multiple moves
between the two modes, hence
degrading the positioning accuracy of
the brain region target.
The procedure described in this work
overcomes all these problems. Indeed,
the main advantage of this imaging
method is the fact that the beam posi-
tion is similar and the spectrum is
adapted in both therapy and imaging
modes. The photon ﬂux reduction is
simply obtained by opening the wiggler
gap instead of inserting the whole
monochromator instrument into the
beam path. The gap aperture from 24.8 (1.6 T) to 120 mm
(0.13 T) reduced the photon ﬂux by a factor of 6   10
3.T h e
photon ﬂux obtained in a single Laue monochromator used
for human angiography was typically 6   10
11 photons s
 1
mm
 2, providing a skin dose of 32 mGy delivered for 1 ms. In
the present case, the intensity of the pink beam was adjusted
to obtain similar detector grey levels dynamics and exposure
times, indicating that the dose delivered was of the same order
of magnitude as the human synchrotron angiography clinical
studies (Bertrand et al., 2005).
The whole procedure between rat positioning on the goni-
ometer and brain irradiation takes less than 3 min. Moreover,
no movement of attenuators and ﬁlters are required in this
new imaging at open wiggler gap since the same set of
attenuators produced satisfactory spectra in both therapy and
imaging mode. The quality of the radiographic image obtained
with the pink beam is comparable with images obtained with
monochromatic beams. Indeed, the pink-beam spectrum
extends from 35 to 60 keV, as shown in Fig. 1. and is centred at
about 46 keV which is in an energy range well adapted for
small-animal X-ray imaging. The resulting contrast provides
an image quality allowing the precise localization of the
targeted brain regions according to the skull structures. The
principal anatomical reference points, such as bregma and
lambda, are clearly identiﬁable on these X-ray images.
Moreover, the properties of the pink beam would not prevent
performing contrast agent enhancement imaging, as the
K-edges of iodine, xenon and gadolinium are 33.17 keV,
34.56 keV and 50.24 keV, respectively, and fall within this
spectrum. Therefore, this new imaging modality opens inter-
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Figure 5
MR imaging of the targeted brain regions in GAERS. T1-weighted images acquired 5 min after
intravenous injection. Gd-DOTA injection of the evolution of the radio-induced lesion at day 15
after irradiation. The thalamus and the somatosensory cortex were precisely targeted using our
alignment procedures (arrows).esting perspectives in the ﬁeld of image-guided tumor irra-
diations based on contrast-agent-enhanced tomographic
imaging. Such an imaging method does not need to be quan-
titative; only tumor localization will be required to deﬁne the
planning of the target volume and tumor margins.
The imaging/alignment procedure described in this work
allows highly reproducible and conﬁned three-dimensional
irradiations. Indeed, nine GAERS rats out of ten received well
targeted irradiations (thalamus or cortex irradiations). The rat
head angle alignment in the AP axis was not checked in the
last animal which induced an error of a few millimetres in the
irradiation site. However, this can be easily corrected by
performing a scan at different angles of rotation along the AP
axis; the horizontality of the skull will be achieved at the angle
where the skull appears the thickest on images (or highest
absorption). To our knowledge, our work constitutes the ﬁrst
image-guided microbeam irradiations. Hence, thanks to the
association of interlaced MRT (Serduc et al., 2010) and this
alignment procedure, the ID17 biomedical beamline provides
a unique tool allowing brain radiosurgery trials on animal
patients. The sharp lateral dose fall-off of the synchrotron light
is about 180 folds higher than the best current clinical devices
such as the gamma knife (Serduc et al., 2010). Indeed, the
function of a given brain region could be studied by selective
radiosurgery ablation without impairing surrounding normal
tissues. This represents a critical step in MRT preclinical
studies and could signiﬁcantly increase the effectiveness of
microbeam irradiations at synchrotron facilities by optimizing
the irradiation ﬁeld size and the positioning, decreasing
thereby the neuro-radiotoxicity.
6. Conclusion
In this work we described an original method for animal
positioning before brain microbeam radiosurgery, using pink-
beam imaging. This procedure allows a 50 mm-accuracy
alignment with a short transition time between imaging and
therapy modalities and vice versa. The combination of three-
dimensional irradiation and pink-beam imaging alignment
appears as a useful and efﬁcient tool in brain pathology
radiation therapy. Future developments, e.g. tomography and
pink-beam contrast agent imaging, will enlarge the potential
use of synchrotron-generated X-rays to image and treat
cancerous diseases.
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